XPhyto Therapeutics (CSE: XPHY- OTCQB: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to bring news the company has announced it has entered into an agreement with an established German pharmaceutical wholesaler and service provider for distribution, storage and logistics of XPhyto's diagnostic products in Germany.
Rogers telling Proactive this now secures XPhyto a full-service distribution partner for its 25-minute COVID-19 RT-PCR test system Roger also says they are currently in discussions with various potential customers, distribution and wholesale partners as well as potential licensees.